{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:50:22Z","timestamp":1793022622216,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.maturitas.2026.109125","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:00:40Z","timestamp":1789052440000},"page":"109125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone health in older men"],"prefix":"10.1016","volume":"214","author":[{"given":"Michail","family":"Krikelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Divaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Anagnostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-324X","authenticated-orcid":false,"given":"Symeon","family":"Tournis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.maturitas.2026.109125_bb0005","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2011-3058","article-title":"Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis","volume":"97","author":"Drake","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109125_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ecl.2021.03.001","article-title":"Updates on osteoporosis in men","volume":"50","author":"Diab","year":"2021","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109125_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch. Osteoporos."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109125_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/13685538.2023.2223699","article-title":"Gaps in evidence on treatment of male osteoporosis: a research agenda","volume":"26","author":"Rose","year":"2023","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.maturitas.2026.109125_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstr\u00f6m","year":"2020","journal-title":"Arch. Osteoporos."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109125_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109125_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11914-017-0352-5","article-title":"Fracture burden: what two and a half decades of Dubbo osteoporosis epidemiology study data reveal about clinical outcomes of osteoporosis","volume":"15","author":"Center","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109125_bb0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.2002.17.4.716","article-title":"Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS)","volume":"17","author":"Felsenberg","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.maturitas.2026.109125_bb0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"14","key":"10.1016\/j.maturitas.2026.109125_bb0050","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","article-title":"Clinical practice. Osteoporosis in men","volume":"358","author":"Ebeling","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2026.109125_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01623429","article-title":"Peak bone mass","volume":"4","author":"Bonjour","year":"1994","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109125_bb0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/JBMR.041005","article-title":"Males have larger skeletal size and bone mass than females, despite comparable body size","volume":"20","author":"Nieves","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109125_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jbmr.262","article-title":"The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?","volume":"26","author":"Khosla","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109125_bb0070","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jbmr.2817","article-title":"Age- and sex-related changes in bone microarchitecture and estimated strength: a three-year prospective study using HR-pQCT","volume":"31","author":"Shanbhogue","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.maturitas.2026.109125_bb0075","first-page":"e5180","article-title":"Bone microarchitecture decline and risk of fall and fracture in men with poor physical performance: the STRAMBO study","volume":"106","author":"Wagner","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109125_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030530","article-title":"Testosterone and bone health in men: a narrative review","volume":"10","author":"Shigehara","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.maturitas.2026.109125_bb0085","first-page":"1","article-title":"Male hypogonadism and osteoporosis: a systematic review","volume":"3","author":"Oduwegwu","year":"2022","journal-title":"J. Endocrinol. Metab. Res."},{"key":"10.1016\/j.maturitas.2026.109125_bb0090","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.109125_bb0095","series-title":"Adult Official Positions","author":"International Society for Clinical Densitometry (ISCD)","year":"2023"},{"key":"10.1016\/j.maturitas.2026.109125_bb0100","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2026.109125_bb0105","series-title":"StatPearls [Internet]","article-title":"Osteoporosis in males","author":"Anastasopoulou","year":"2026"},{"key":"10.1016\/j.maturitas.2026.109125_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41584-024-01094-9","article-title":"Evidence-based guideline for the management of osteoporosis in men","volume":"20","author":"Fuggle","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.maturitas.2026.109125_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bone.2017.03.004","article-title":"Vertebral fracture assessment: enhancing the diagnosis, prevention, and treatment of osteoporosis","volume":"104","author":"Zeytinoglu","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2026.109125_bb0120","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2026.109125_bb0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","article-title":"An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis","volume":"47","author":"Schini","year":"2024","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"10.1016\/j.maturitas.2026.109125_bb0130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40618-024-02517-w","article-title":"Male osteoporosis: the impact of lifestyle, from nutrition to physical activity","volume":"48","author":"Defeudis","year":"2025","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.maturitas.2026.109125_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/875249","article-title":"Calcium and vitamin D supplementation in men","volume":"2011","author":"Gielen","year":"2011","journal-title":"J. Osteoporos."},{"issue":"9","key":"10.1016\/j.maturitas.2026.109125_bb0140","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s40520-023-02478-9","article-title":"Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis","volume":"35","author":"Beaudart","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"issue":"18","key":"10.1016\/j.maturitas.2026.109125_bb0145","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109125_bb0150","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109125_bb0155","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jc.2014-4079","article-title":"A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial","volume":"100","author":"Langdahl","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2026.109125_bb0160","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1210\/jc.2013-4175","article-title":"Clinical trials express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo-controlled trial (DIRECT)","volume":"99","author":"Nakamura","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.109125_bb0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00198-024-07381-1","article-title":"Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study","volume":"36","author":"Huang","year":"2025","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109125_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"13","key":"10.1016\/j.maturitas.2026.109125_bb0175","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109125_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1579101","article-title":"The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and Bayesian network meta-analysis","volume":"16","author":"Chai","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"12","key":"10.1016\/j.maturitas.2026.109125_bb0185","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/jbmr.4719","article-title":"The efficacy and safety of abaloparatide-SC in men with osteoporosis: a randomized clinical trial","volume":"37","author":"Czerwinski","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.maturitas.2026.109125_bb0190","doi-asserted-by":"crossref","first-page":"e4222","DOI":"10.1210\/clinem\/dgac486","article-title":"Abaloparatide increases lumbar spine and hip BMD in Japanese patients with osteoporosis: the phase 3 ACTIVE-J study","volume":"107","author":"Matsumoto","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2026.109125_bb0195","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis","volume":"103","author":"Lewiecki","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.109125_bb0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.22514\/jomh.2025.015","article-title":"Clinical efficacy of romosozumab in the treatment of elderly male patients with osteoporotic hip fractures: a retrospective study","volume":"21","author":"Yichao","year":"2025","journal-title":"J. Mens Health"},{"issue":"5","key":"10.1016\/j.maturitas.2026.109125_bb0205","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.109125_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2026.108961","article-title":"Effect of testosterone replacement therapy on fracture risk in hypogonadal men: a systematic review and meta-analysis of randomized controlled trials","volume":"209","author":"Anagnostis","year":"2026","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.maturitas.2026.109125_bb0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2026.109125_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656566.9.2.211","article-title":"Androgen deprivation therapy for prostate cancer","volume":"9","author":"Singer","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.maturitas.2026.109125_bb0225","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109125_bb0230","series-title":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 5.2026","author":"National Comprehensive Cancer Network","year":"2026"},{"issue":"9","key":"10.1016\/j.maturitas.2026.109125_bb0235","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.2301","article-title":"The osteoporosis treatment gap","volume":"29","author":"Kanis","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"19","key":"10.1016\/j.maturitas.2026.109125_bb0240","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","article-title":"Undertreatment of osteoporosis in men with hip fracture","volume":"162","author":"Kiebzak","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2026.109125_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027049","article-title":"Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review","volume":"9","author":"Fatoye","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.maturitas.2026.109125_bb0250","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"Hiligsmann","year":"2019","journal-title":"Osteoporos. Int."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226003026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226003026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:19:27Z","timestamp":1793020767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226003026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0378512226003026"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109125","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health in older men","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109125"}}